Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq ...

Read also: Shilpa Medicare announces submission of NDA for Oxylanthanum Carbonate to USFDA by Unicycive Therapeutics Shilpa ...

The Supreme Court yesterday (November 12) heard a petition seeking directions from the Union, the States and Union ...